Australian
ACL.AXAustralian Clinical Labs Limited Price (ACL.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
199,472,019
(0.8173)%2024 - Income Statement Summary
| Revenue | 689.73M USD |
| Cost of Revenue | 442.37M USD |
| Gross Profit | 247.36M USD |
| Operating Expenses | 81.55M USD |
| Operating Income | 56.91M USD |
| Other Expenses | 201.83M USD |
| Net Income | 23.93M USD |
Income Statement
Australian Clinical Labs LimitedCurrency: AUD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
339,768,000.00
+0% |
376,088,000.00
+11% |
445,890,000.00
+19% |
487,530,000.00
+9% |
641,311,000.00
+32% |
989,298,000.00
+54% |
692,103,000.00
-30% |
689,728,000.00
0% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 57,679,000.00 | 265,846,000.00 | 313,893,000.00 | 402,489,000.00 | 119,585,000.00 | 207,592,000.00 | 126,083,000.00 | 442,368,000.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
282,089,000.00
+0% |
110,242,000.00
-61% |
131,997,000.00
+20% |
85,041,000.00
-36% |
521,726,000.00
+513% |
781,706,000.00
+50% |
566,020,000.00
-28% |
247,360,000.00
-56% |
|||||||||||
| Gross Profit Ratio | (0.83%) | (0.29%) | (0.30%) | (0.17%) | (0.81%) | (0.79%) | (0.82%) | (0.36%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 249,685,000.00 | 314,003,000.00 | 297,394,000.00 | 312,668,000.00 | |||||||||||
| Selling, General & Admin... | 251,501,000.00 | 116,151,000.00 | 139,575,000.00 | 69,509,000.00 | 249,685,000.00 | 314,003,000.00 | 297,394,000.00 | 87,193,000.00 | |||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -225,475,000.00 | |||||||||||
| Depreciation and Amortiz... | 12,510,001.00 | 11,318,000.00 | 11,506,000.00 | 77,902,000.00 | 88,052,000.00 | 106,096,000.00 | 122,755,000.00 | 128,426,999.00 | |||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 3,357,000.00 | -1,073,000.00 | 10,026,000.00 | 201,828,000.00 | |||||||||||
| Total Operating Expenses | 306,323,000.00 | 116,151,000.00 | 139,575,000.00 | 69,509,000.00 | 416,536,000.00 | 514,029,000.00 | 514,053,000.00 | 81,547,000.00 | |||||||||||
| Cost and Exponses | 364,002,000.00 | 381,997,000.00 | 453,468,000.00 | 471,998,000.00 | 536,121,000.00 | 721,621,000.00 | 640,136,000.00 | 632,823,000.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-20,569,000.00
+0% |
-5,909,000.00
-71% |
-7,578,000.00
+28% |
15,532,000.00
-305% |
97,592,000.00
+528% |
256,239,000.00
+163% |
51,850,000.00
-80% |
56,905,000.00
+10% |
|||||||||||
| Operating Income Ratio | (-0.06%) | (-0.02%) | (-0.02%) | (0.03%) | (0.15%) | (0.26%) | (0.07%) | (0.08%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 3,378,000.00 | 47,000.00 | 38,000.00 | 38,000.00 | 75,000.00 | 45,000.00 | 182,000.00 | 501,000.00 | |||||||||||
| Interest Expenses | 0.00 | 3,645,000.00 | 3,940,000.00 | 16,565,999.00 | 10,939,000.00 | 1,339,000.00 | 3,540,000.00 | 17,040,000.00 | |||||||||||
| Total Other Income/Exp... | -58,200,000.00 | -1,732,000.00 | 2,378,000.00 | 1,168,000.00 | -35,957,000.00 | -12,777,000.00 | -3,657,000.00 | -20,539,000.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -8,058,999.00 | 5,409,000.00 | 3,928,000.00 | 116,300,000.00 | 196,674,000.00 | 372,745,000.00 | 184,930,000.00 | 169,650,000.00 | |||||||||||
| EBITDA ratio | (-0.02%) | (0.01%) | (0.01%) | (0.19%) | (0.29%) | (0.37%) | (0.25%) | (0.25%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -27,612,000.00 | -7,641,000.00 | -9,704,000.00 | 30,891,000.00 | 86,653,000.00 | 254,900,000.00 | 48,310,000.00 | 36,366,000.00 | |||||||||||
| Income Before Tax Ratio | (-0.08%) | (-0.02%) | (-0.02%) | (0.06%) | (0.14%) | (0.26%) | (0.07%) | (0.05%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 3,581,000.00 | 1,371,000.00 | 820,000.00 | -10,425,000.00 | 26,264,000.00 | 76,498,000.00 | 12,268,000.00 | 12,122,000.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -24,031,000.00
+0% |
-9,012,000.00
-62% |
-10,524,000.00
+17% |
41,255,000.00
-492% |
60,373,000.00
+46% |
178,244,000.00
+195% |
35,901,000.00
-80% |
23,934,000.00
-33% |
|||||||||||
| Net Income Ratio | (-0.07%) | (-0.02%) | (-0.02%) | (0.08%) | (0.09%) | (0.18%) | (0.05%) | (0.03%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.12 | -0.04 | -0.05 | 0.20 | 0.40 | 0.89 | 0.18 | 0.12 | |||||||||||
| Diluted EPS | -0.12 | -0.04 | -0.05 | 0.20 | 0.40 | 0.88 | 0.18 | 0.12 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 202,300,000.00 | 202,300,000.00 | 202,300,000.00 | 202,300,000.00 | 152,104,480.00 | 201,291,659.00 | 200,568,042.00 | 198,904,689.00 | |||||||||||
| Diluted Share Outstanding | 202,300,000.00 | 202,300,000.00 | 202,300,000.00 | 202,300,000.00 | 152,104,480.00 | 201,486,594.00 | 201,115,660.00 | 199,472,019.00 | |||||||||||